Comprehensive CBT (Cognitive Behavioral Therapy) Via reSET App
1 other identifier
interventional
15
1 country
1
Brief Summary
This research is being done to find out whether an app based cognitive behavior therapy called reSET improves the adherence to and outcome of buprenorphine treatment for opioid use disorder (OUD) in the setting of a Hub and Spoke implementation system.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 11, 2019
CompletedFirst Posted
Study publicly available on registry
February 1, 2019
CompletedStudy Start
First participant enrolled
March 4, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2020
CompletedJuly 8, 2020
July 1, 2020
11 months
January 11, 2019
July 7, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Retention in treatment on MAT for 6 months after enrolling in the study
ReSET is a mobile app designed to provide extended cognitive behavioral therapy for patients initiating medication assisted treatment (MAT) for opioid use disorder (OUD). This pilot trial is evaluating the acceptability and feasibility of the app, reSET. The first outcome being measure is treatment retention. We want to examine if participants enrolled in the study will maintain on MAT for 6 months after enrollment. This will be evaluated based on the number of appointments attended by the research participants. Data mining through our systems electronic medical record (EMR) will be conducted in order to count the number of attended appointments for study participants to gauge their treatment retention.
6 months
Secondary Outcomes (12)
Opioid and other substance abuse as assessed through biological specimen
6 months
Opioid and other substance abuse as assessed through participant self-report
6 months
Cravings to use drugs as assessed by the reSET app
6 months
Overall mental health symptoms related to depression and anxiety as assessed by the K-10
6 months
Mental health symptoms specific to depression as assessed by the PHQ-9
6 months
- +7 more secondary outcomes
Interventions
reSET is a mobile app created by Pear Therapeutics, Inc., which has previously been approved by the FDA.
Eligibility Criteria
You may qualify if:
- years of age or older
- Starting outpatient treatment for OUD within the PACMAT Hub and Spoke system (either the Hub or one of the Spokes)
- Planning maintenance treatment with buprenorphine
- Willing to participate in the study
- Can read, write and comprehend English
You may not qualify if:
- Planning an outpatient detoxification, or treatment other than buprenorphine maintenance (e.g. methadone maintenance, Vivitrol, or counseling with no medication)
- Judged by the evaluating physician or allied clinician to need a higher level of care (e.g. residential or inpatient treatment)
- Unwilling to participate in the study
- Under the age of 18
- Unable to read, write and comprehend English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Milton S. Hershey Medical Centerlead
- Columbia Universitycollaborator
- Research Foundation for Mental Hygiene, Inc.collaborator
Study Sites (1)
Pennsylvania Psychiatric Institute, Opioid Treatment Program
Harrisburg, Pennsylvania, 17110, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- N/A at this time. This trial is a pilot study seeking an N of 15 participants. All participants will be assigned the "treatment," which is accessing an mobile app, re-SET, for cognitive behavioral therapy extension that is to be used with MAT (Buprenorphine only at this time).
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
January 11, 2019
First Posted
February 1, 2019
Study Start
March 4, 2019
Primary Completion
January 31, 2020
Study Completion
January 31, 2020
Last Updated
July 8, 2020
Record last verified: 2020-07